UnitLevel 4Undergraduate

PHR4042 Integrated care

Faculty of Pharmacy and Pharmaceutical Sciences

PHR4042 Integrated care is a level 4, 12-credit-point, undergraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2022 in Semester 2 at Malaysia and Parkville. It needs PHR1011, PHR1022, PHR2041, PHR2021, PHR3062, PHR1031, PHR2141, PHR3041, PHR3042, PHR1012, PHR2011, PHR2042, PHR3141, PHR5151, PHR1021, PHR2012, PHR2142, PHR5052 and PHR4061.

Credit points
12
Offered in 2022
Semester 2
Malaysia, Parkville
Assessment
Exam 40%
and 6 other tasks

This is the 2022 handbook entry. See the 2027 entry.

Reviews

No reviews yet

No reviews yet. Be the first to review PHR4042.

Requisites

Overview

This unit challenges you to apply your knowledge and skills obtained in Comprehensive Care and Professional Practice units to address the overall medical and social needs of patients over their healthcare journey. This unit will explore familiar and unfamiliar acute and chronic illnesses and determinants of health that are pertinent to women's and men's health and other key patient populations: including, but not limited to, paediatric, geriatric, Indigenous and rural communities. Knowledge of pathophysiology, pharmacology, therapeutics and evidence-based practice will be integrated to guide therapeutic decision making and medication management. You will be encouraged to think holistically about, advocate for, and promote the health and well-being of different patients and patient populations. It will also provide you with skills to better engage with an integrated healthcare system.

Offerings in 2022

Teaching periodCampusMode
Second semesterMalaysiaOn campus
Second semesterParkvilleOn campus

Assessment

  • Readiness Assurance tests
    10%
  • Mid semester test
    5%
  • Integrated care case-based discussions - MMoC Patient Management Plans
    25%
  • Integrated care case-based discussion-therapeutic reasoning
    5%
  • Health promotion proposal
    10%
  • End of semester test
    5%
  • Final Examination: Objective Structured Clinical Examination Part ACompetency hurdle
    20%
  • Final Examination: Objective Structured Clinical Examination Part B
    20%

Learning outcomes

When you finish this unit, you should be able to:

  1. 1

    Describe the epidemiology, signs and symptoms of acute and chronic illnesses pertinent to key patient populations

  2. 2

    Explain mechanisms of action for drugs used in the treatment of a variety of familiar and unfamiliar acute and chronic illnesses that are pertinent to key patient populations, and relate this to disease management and possible side effects

  3. 3

    Explain how pharmacokinetic and pharmacodynamic changes pertinent to key patient populations influence therapeutic decision making and medication management

  4. 4

    Create a patient-centred care plan (Monash Model of CARE plan) which applies established clinical guidelines and evidence-based principles to optimally manage the healthcare needs of a patient in an integrated manner:

    • Gather and integrate information concerning the pharmacology of medicines, patient-specific factors and evidence-based literature to optimally manage overall patient well-being
    • List and prioritise drug and non-drug therapy options for the management and prevention of unfamiliar and familiar illness
    • Incorporate patient-specific factors and evidence-based principles to justify and defend recommended management options
    • Develop strategies to evaluate responses to a recommended patient management plan
    • Evaluate and justify when a referral is required to other health professionals or care providers to achieve optimal integrated patient care
    • Develop, apply and communicate education strategies that provide support and optimise patient-centred relationships and outcomes
    • Reflect on the development and implementation of the Monash Model of CARE plan
  5. 5

    Explain how social determinants of health can impact the health of key populations and the provision of socially accountable healthcare in both Australian and global health contexts                                                                                                                

  6. 6

    Design strategies to promote and advocate for societal health and well-being, including addressing environmental concerns and being socially accountable to the needs of specific populations such as remote and/or Indigenous populations                               

  7. 7

    Using a multidisciplinary healthcare team approach, develop and articulate appropriate clinical and communication strategies to ensure an integrated continuum of patient care                                                                   

  8. 8

    Demonstrate proficiency in simulated clinical settings by applying clinical reasoning and collaborative decision making to communicate a medication management plan that optimises a patient’s integrated healthcare needs

Workload and teaching

  • Lectures18 hours
  • Applied sessions16 hours
  • Assessments6 hours
  • Workshops36 hours
  • One hundred and forty-four hours of independent study
  • Forty-eight hours of pre-learning activities (up to 4 hours per week)
  • Forty-eight hours of active learning lectures (4 hours per week)
  • Forty-eight hours of small group classes including assessment (4 hours per week)

Learning resources

Required resources

Australian Medicines Handbook (AMH)

Australian Pharmaceutical Formulary (APF)

Therapeutic guidelines

MIMS Online

Recommended resources

Rang, Dale, Ritter and Flower; Rang and Dale’s Pharmacology, 8th edition, 2016 - Optional

Pharmacology for Health Professionals, 4th edition, 2014 – Optional

Paediatrics [Chapter 9] in Community pharmacy: Symptoms, diagnosis and treatment
Chapter by D Newby; P Rutter 2011

Technology resources

For more information on Bring Your Own Device (BYOD) specifications and the technology systems and services available to students, review the Student Technology Essentials Handbook https://www.monash.edu/__data/assets/pdf_file/0010/1041220/student-it-brochure.pdf

Contacts

Chief Examiners
Dr Stefan Huth
Unit Coordinators
Dr Siew Li Teoh
Dr Stefan Huth

Common questions

What are the prerequisites for PHR4042?

You need PHR1011, PHR1022, PHR2041, PHR2021, PHR3062, PHR1031, PHR2141, PHR3041, PHR3042, PHR1012, PHR2011, PHR2042, PHR3141, PHR5151, PHR1021, PHR2012, PHR2142, PHR5052 and PHR4061 before you enrol. Enrolment rules also apply.

When is PHR4042 offered?

In 2022, PHR4042 runs in Semester 2 at Malaysia and Parkville.

Does PHR4042 have an exam?

Yes. The exam is worth 40% of the final mark, alongside 7 other tasks.

More details

Credit points
12
Level
4
Study level
Undergraduate
Faculty
Faculty of Pharmacy and Pharmaceutical Sciences
Type
Coursework
EFTSL
0.250
Student contribution
SCA Band 2
Study abroad
Not available